Reuters exclusively reported that buyout firm Carlyle Group has delayed the U.S. initial public offering (IPO) of its German specialty chemicals group Atotech over concern that the coronavirus outbreak would negatively impact the valuation it could achieve with investors. Carlyle’s decision highlights the uncertainty that the spread of the virus in China and around the world has brought to financial markets.
Reuters exclusively reports coronavirus outbreak delays Carlyle’s Atotech IPO
31 January 2020, 12:00 am. 1 minute
Article Tags
Type: Reuters Best
Sectors: Equities
Regions: Europe / Middle East / Africa
More of Reuters Best
Reuters exclusively reports Indian sugar mills to close early as rain hits cane supply; sugar futures jump; shares fall
January 29, 2023
Reuters reveals that India may peg gross borrowing under 16 trillion rupees in 2023/24
January 27, 2023